What is MapLight Therapeutics, Inc. 's current ratio?

MapLight Therapeutics, Inc. (MPLT) reported current ratio of 22.9× in Q1 2026.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

MapLight Therapeutics, Inc. MPLT Current ratio

Current ratio at other companies

Bristol-Myers SquibbBMY

1.4×+0.1×

Johnson & JohnsonJNJ

1×-0.2×

Neurocrine BiosciencesNBIX

2.9×-0.2×

Acadia PharmaceuticalsACAD

3.6×+0.7×

AbbVieABBV

0.8×0.0×

LBR

LB Pharmaceuticals Inc Common StockLBRX

35.7×—

Other financials

Income statement

See full

Operating income-$64.5M-174%

Net income-$60.7M-172%

EPS (diluted)-$1.34+95.4%

Balance sheet

See full

Cash & equivalents$55.7M—

Total debt$5.6M—

Total equity$399.8M+285%

Total assets$418.8M—

Cash flow

See full

Operating cash flow-$51.2M-100%

CapEx$24.0K—

Free cash flow-$51.2M—

Valuation

See full

Market cap$1.39B—

Enterprise value$1.34B—

Returns & leverage

See full

Return on equity-216.8%—

Debt / equity0×—

Where this comes from

Calculated from MapLight Therapeutics, Inc. ’s reported figures.

total current assets/total current liabilities=22.9×

Based on the most recent quarter.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's current ratio?: MapLight Therapeutics, Inc. (MPLT) reported current ratio of 22.9× in Q1 2026.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.